Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Molecular Pharmacology|October 14, 2005
Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8Christopher A Haskell, Richard Horuk, Meina Liang, et al.Journal of Biomolecular Structure & Dynamics|November 21, 2022
Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking studyZahra Abdulkarim Homoud, Muhammad Taha, Fazal Rahim, et al.Bioorganic & Medicinal Chemistry Letters|April 10, 2018
Reversible, orally available ADP receptor (P2Y<sub>12</sub>) antagonists Part I: Hit to lead processImadul Islam, Shendong Yuan, Robert G Wei, et al.Thrombosis Research|May 23, 2008
Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on plateletsJudi Bryant, Joseph M Post, Serene Alexander, et al.ACS Medicinal Chemistry Letters|June 19, 2024
Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase InhibitorsJaydeo T Kilbile, Suryakant B Sapkal, Gioele Renzi, et al.Journal of Biomolecular Structure & Dynamics|April 16, 2021
Synthesis of new urease enzyme inhibitors as antiulcer drug and computational studyMuhammad Taha, Sukinah Ismail, Syahrul Imran, et al.Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterizationYi-Xin Wang, Lei Zhao, Mariko Nagashima, et al.Thrombosis and Haemostasis|January 4, 2007
A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosisYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activityImadul Islam, Judi Bryant, Yuo-Ling Chou, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517Imadul Islam, Greg Brown, Judi Bryant, et al.Pageof 4